Возраст домена | 15 лет |
Дата окончания | Истек срок регистрации |
PR | 5 |
ИКС | |
Страниц в Google | 5110 |
Страниц в Яндексе | 92 |
Dmoz | Нет |
Яндекс Каталог | Нет |
Alexa Traffic Rank | 12992225 |
Alexa Country | Нет данных |
История изменения показателей | Авторизация |
Идет сбор информации... Обновить
Pharma Strategy Blog
n/a
n/a
UTF-8
31.5 КБ
234
1 866 симв.
1 562 симв.
Данные предоставлены сервисом semrush
Сайт | Общие фразы | PR | тИЦ | Alexa Rank | Alexa Country | |
---|---|---|---|---|---|---|
![]() ![]() |
48 | 8 |
0 | 157672 | ![]() | |
![]() ![]() |
41 | 9 |
0 | 5 | ![]() | |
![]() ![]() |
40 | 8 |
0 | 113 | ![]() | |
![]() |
25 | 7 |
0 | 22356 | ![]() | |
![]() ![]() |
24 | 7 |
0 | 2705 | ![]() | |
![]() ![]() |
22 | 9 |
0 | 740 | ![]() | |
![]() ![]() |
17 | 8 |
0 | 9304 | ![]() | |
![]() |
16 | 9 |
0 | 326878 | ![]() | |
![]() ![]() |
12 | 7 |
0 | 30220 | ![]() | |
![]() |
12 | 6 |
0 | Нет данных | ![]() |
|
![]() ![]() |
4 | 6 |
20 | 1702719 | ![]() |
|
![]() |
4 | 5 |
10 | 1005554 | ![]() | |
![]() ![]() |
2 | 6 |
50 | 88694 | ![]() | |
![]() ![]() ![]() |
1 | 5 |
120 | 25660 | ![]() | |
![]() |
1 | n/a | 0 | 9415490 | ![]() |
|
![]() |
1 | n/a | 0 | 15884463 | ![]() |
|
![]() |
1 | 4 |
0 | 16414013 | ![]() |
|
![]() |
1 | 4 |
0 | 1027557 | ![]() | |
Еще 32 сайта после авторизации |
Данные предоставлены сервисом semrush
Счетчик | Посетители за 24 часа | Просмотры | Просмотров на посетителя |
---|---|---|---|
![]() | Нет доступа | Нет доступа | n/a |
Данные linkpad ( 12 Ноября 2016 ) | |
Количество ссылок на сайт | 2576 |
Количество доменов, которые ссылаются на сайт | 122 |
Количество найденных анкоров | 99 |
Исходящие (внешние) ссылки домена | 921 |
Количество доменов, на которые ссылается сайт | 159 |
Количество исходящих анкоров | 227 |
Внешние ссылки главной страницы ( 2 ) | |
biotechstrategyblog.com | Biotech Strategy Blog |
noveltargets.com | Novel Targets |
Внутренние ссылки главной страницы ( 20 ) | |
pharmastrategyblog.com/ | Pharma Strategy Blog |
pharmastrategyblog.com/blog/ | Posts |
pharmastrategyblog.com/about/ | About |
pharmastrategyblog.com/kol-interviews/ | KOL Interviews |
pharmastrategyblog.com/science-fridays/ | Science Fridays |
pharmastrategyblog.com/contact/ | Contact |
pharmastrategyblog.com/sign-up-pharma-strategy-blog/ | Sign Up |
pharmastrategyblog.com/2014/02/developing-a-predictive-bioma... | E Developing a predictive biomarker for PARP inhibition Is CDK12 deficiency a clinically relevant predictive ... |
pharmastrategyblog.com/2014/01/update-on-raf-resistance-in-m... | E Update on RAF resistance in metastatic melanoma The state of play in overcoming resistance to RAF inhibitio... |
pharmastrategyblog.com/2014/01/red-and-green-flags-in-cancer... | Red and Green Flags in cancer research and development Read more |
pharmastrategyblog.com/2014/01/will-intermittent-dosing-tran... | Will intermittent dosing transform TKI therapy in cancer research? Read more |
pharmastrategyblog.com/2014/01/making-a-difference-in-nhl-an... | E Making a difference in NHL and CLL: an interview with Dr Carol Gallagher Dr Carol Gallagher is the former C... |
pharmastrategyblog.com/2013/10/medivation-announce-interim-r... | Medivation announce interim results of PREVAIL in pre-chemotherapy CRPC Read more |
pharmastrategyblog.com/2013/10/can-merck-make-an-impact-in-p... | Can Merck make an impact in pancreatic cancer? Read more |
pharmastrategyblog.com/2013/10/removing-the-pd-1-brake-enhan... | Removing the PD-1 brake enhances the effect on adoptive CAR T cells Read more |
pharmastrategyblog.com/2013/09/update-on-kras-and-nras-mutat... | Update on KRAS and NRAS mutations in colorectal cancer Read more |
pharmastrategyblog.com/2013/09/whats-hot-at-ecco-2013-previe... | What’s hot at ECCO 2013 – Preview of late breakers and PI3K abstracts Read more |
pharmastrategyblog.com/2013/04/overcoming-drug-resistance-in... | Overcoming drug resistance in lung cancer Read more |
pharmastrategyblog.com/2013/02/making-a-difference-in-advanc... | Making a difference in Advanced Prostate Cancer – an interview with Bertrand Tombal Read more |
pharmastrategyblog.com/terms-of-use/ | Terms of Use |
Domain Name: PHARMASTRATEGYBLOG.COM
Registry Domain ID: 1518234111_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.tucows.com
Registrar URL: http://tucowsdomains.com
Updated Date: 2018-09-23T18:45:21
Creation Date: 2008-09-06T21:26:03
Registrar Registration Expiration Date: 2020-09-06T21:26:03
Registrar: TUCOWS, INC.
Registrar IANA ID: 69
Reseller: Hover
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Registry Registrant ID:
Registrant Name: Contact Privacy Inc. Customer 0129962973
Registrant Organization: Contact Privacy Inc. Customer 0129962973
Registrant Street: 96 Mowat Ave
Registrant City: Toronto
Registrant State/Province: ON
Registrant Postal Code: M6K 3M1
Registrant Country: CA
Registrant Phone: +1.4165385457
Registrant Phone Ext:
Registrant Fax:
Registrant Fax Ext:
Registrant Email: pharmastrategyblog.com@contactprivacy.com
Registry Admin ID:
Admin Name: Contact Privacy Inc. Customer 0129962973
Admin Organization: Contact Privacy Inc. Customer 0129962973
Admin Street: 96 Mowat Ave
Admin City: Toronto
Admin State/Province: ON
Admin Postal Code: M6K 3M1
Admin Country: CA
Admin Phone: +1.4165385457
Admin Phone Ext:
Admin Fax:
Admin Fax Ext:
Admin Email: pharmastrategyblog.com@contactprivacy.com
Registry Tech ID:
Tech Name: Contact Privacy Inc. Customer 0129962973
Tech Organization: Contact Privacy Inc. Customer 0129962973
Tech Street: 96 Mowat Ave
Tech City: Toronto
Tech State/Province: ON
Tech Postal Code: M6K 3M1
Tech Country: CA
Tech Phone: +1.4165385457
Tech Phone Ext:
Tech Fax:
Tech Fax Ext:
Tech Email: pharmastrategyblog.com@contactprivacy.com
Name Server: ns1.hover.com
Name Server: ns2.hover.com
Registrar Abuse Contact Email: domainabuse@tucows.com
Registrar Abuse Contact Phone: +1.4165350123
>>> Last update of WHOIS database: 2018-09-23T18:45:21 <<<
"For more information on Whois status codes, please visit https://icann.org/epp"
User-agent: *
Disallow: /wp-admin/
Disallow: /wp-includes/
Disallow: /images/
Disallow: /uploads/
Noarchive: /
User-agent: Googlebot-Image
Disallow: /
Disallow: /blog/
Disallow: /uploads/
Disallow: /images/
User-agent: ia_archiver
Disallow: /
Россия - Москва - 217.65.11.122
Filanco, ltd.
Filanco, ltd.
HTTP/1.1 200 OK
Server: nginx
Date: Tue, 21 Jan 2020 11:45:17 GMT
Content-Type: text/html; charset=UTF-8
Content-Length: 32253
Connection: keep-alive
Keep-Alive: timeout=20
Vary: Accept-Encoding
Vary: Accept-Encoding
Link: ; rel="https://api.w.org/"
Link: ; rel=shortlink
X-Powered-By: WP Engine
X-Cacheable: SHORT
Vary: Accept-Encoding,Cookie
Cache-Control: max-age=600, must-revalidate
X-Cache: HIT: 2
X-Pass-Why:
X-Cache-Group: normal
Accept-Ranges: bytes
Кнопка для анализа сайта в один клик, для установки перетащите ссылку на "Панель закладок"